Abstract

RANDOMISED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF ELADI VATI WITH LAJAAMBU IN GARBHINI CHHARDI WITH SPECIAL REFERENCE TO HYPEREMESIS GRAVIDARUM

Dr. Mohini Magar* and Dr. Veena A. Patil

Abstract

Background: Garbhini Chhardi (nausea and vomiting in pregnancy) is a common physiological condition, which, when severe, manifests as Hyperemesis Gravidarum (HG), leading to dehydration, weight loss, and maternal-fetal complications. Conventional treatments may have side effects, necessitating safe Ayurvedic alternatives. Objective: To evaluate the efficacy of Eladi Vati with Lajaambu in the management of Garbhini Chhardi, with special reference to Hyperemesis Gravidarum. Methods: A randomized controlled clinical trial was conducted with 60 participants (30 in each group). The trial group received Eladi Vati with Lajaambu, while the control group was treated with Doxylamine Succinate and Pyridoxine Hydrochloride. The study assessed vomiting frequency, anorexia, and weakness, and statistical analysis was performed. Results: Both groups showed significant symptom reduction (p < 0.001). In the trial group, 30% were cured, and 70% improved, while in the control group, 66.7% were cured, and 33.3% improved. No side effects were reported. Ayurvedic pharmacodynamics suggest that Eladi Vati’s Deepana and Pachana actions enhance digestion, while Lajaambu’s Sheet and Tarpana properties aid hydration and nutrition. Conclusion: Eladi Vati with Lajaambu is an effective and safe alternative for Garbhini Chhardi, acting systemically through Agnivardhana and Tridoshahara properties. It supports maternal and fetal health by enhancing digestion, preventing malnutrition, and aiding Rasadhatu formation, thus offering long-lasting benefits. Further research is recommended to establish its broader clinical applications.

Keywords: Garbhini Chhardi, Hyperemesis Gravidarum, Eladi Vati, Lajaambu, Ayurvedic treatment, pregnancy nausea, Deepana, Pachana, Agnivardhana, Tridoshahara, Rasadhatu, maternal health, fetal development.